| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.0072 | 1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |